Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol in the treatment of schizophrenia
IRCT201407151556N61Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of cilostazol in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Aug 2014; status: completed.
02
Drugs
cilostazol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201407151556N61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201407151556N61.